Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
01/2011
01/26/2011CN101336975B Traditional Chinese medicine ointment for treating dermatophytosis
01/26/2011CN101279018B Chinese medicine naoxueshu preparations
01/26/2011CN101273981B Preparation and method for treating diabetes
01/26/2011CN101270101B Method for preparing potassium sodium dehydroandroan drographolide succinate for injection and its freeze-dried injection
01/26/2011CN101249219B Paste for curing idiopathic facial nerve paralysis disease and preparation method thereof
01/26/2011CN101240002B Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof
01/26/2011CN101237852B Liquid formulations
01/26/2011CN101234188B Pharmaceutical composition for treating pain and preparation thereof
01/26/2011CN101224280B Lick brick for treating animal nutrient metabolism disease
01/26/2011CN101224237B Novel uses of compound seabuckthorn seed oil in preparing medicine
01/26/2011CN101214280B Chinese medicine for treating burn, scald and sores and preparation thereof
01/26/2011CN101199790B Chinese medicine for treating asthma
01/26/2011CN101185640B Lomoxicam sustained release tablet and preparation method thereof
01/26/2011CN101181235B Tantudinun sustained-release implantation agent for curing entity tumour
01/26/2011CN101181231B Sustained-release implantation agent of urotrotiken
01/26/2011CN101167974B Quality control method of 'xuhanting' preparation
01/26/2011CN101095950B Hydrophobia vaccine freezing drying preparations for stable human beings and the preparations thereof
01/26/2011CN101085270B Vein-relaxing damp-dispelling capsule
01/26/2011CN101066259B Solid dispersion of higher fatty alcohol and its prepn
01/26/2011CN101058561B Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof
01/26/2011CN101045063B Clarithromycin water soluble preparation for injection use
01/26/2011CN101019945B Hepatitis treating Chinese medicine composition soft capsule
01/26/2011CN101002849B Traditional Chinese medicine extractive or tablet for treating hepatitis, and its preparing method
01/25/2011USRE42072 High transport rates of hormones delivered across cell membranes, facilitating more efficient delivery of drugs and diagnostic agents by using a viscous fluid comprising a polysaccharide a form of hydrogel, lipogel or sols; drug delivery to mucous membranes; gastrointesinal systems
01/25/2011US7875697 Poly(orthoester) polymers, and methods of making and using same
01/25/2011US7875677 Micellar drug delivery systems for hydrophobic drugs
01/25/2011US7875651 Epicatechin for hypertension treatment
01/25/2011US7875590 using an injectable or implantable rod-shaped formulation for delivery of osteogenic proteins to treat osteoporotic and/or osteopenic bone; bone morphogenic proteins
01/25/2011US7875588 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives
01/25/2011US7875310 Residual solvent extraction method and microparticles produced thereby
01/25/2011US7875306 Completely-soluble solid particle(s) based on dietary fibre(s)
01/25/2011US7875297 administering to the uterine cavity a plurality of physiologically inert beads bearing a tissue necrosing amount of silver nitrate as a solid silver ion source;
01/25/2011US7875295 High shear precipitation; faster, higher yield of microparticles or nanoparticles
01/25/2011US7875294 applying a hydrophilic foam ( isophoron diisocyanate end capped polyoxyethylene glycol) substrate and a polymeric hydrophilic agent ( starach grafted copolymer of acrylic acid-acylamide sodium salt) to a portion of the surface of bruised skin reduce the severity of bruising (result of surgery, injury)
01/25/2011US7875293 Biointerface membranes incorporating bioactive agents
01/25/2011US7875292 Orally disintegrable tablets
01/25/2011US7875291 Nutritional supplement, for managing metabolic disorders; first formulation including minerals e.g magnesium glycinate, manganese sulfate, selenium, vanadyl sulfate), zinc gluconate), copper gluconate, iodine, boron and various vitamins; second pacakge include esssential fatty acid; dosage form
01/25/2011US7875290 Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
01/25/2011US7875289 Compositions of less immunogenic and long-circulating protein-lipid complexes
01/25/2011US7875288 such as hemophilia, by administering lipidic nanoparticles comprising phosphatidylcholine, phosphatidylinositol and cholesterol; use when the individual has developed the side effect of antibodies to Factor VIII
01/25/2011US7875270 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
01/25/2011US7875022 Portable infusion pump and media player
01/25/2011CA2642851C Low flush niacin formulation
01/25/2011CA2628200C Solid pharmaceutical compositions containing pregabalin
01/25/2011CA2594710C Topical bioadhesive formulations
01/25/2011CA2541599C Blister pack and solid dosage form therefor
01/25/2011CA2496540C Stable ophthalmic solution comprising latanoprost as active ingredient
01/25/2011CA2483090C Use of therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions
01/25/2011CA2477714C New cinnamic acid salts, processes for the preparation thereof and use thereof as medicament
01/25/2011CA2459327C Implantable infusion device and reservoir for same
01/25/2011CA2449066C Nicotine-containing film preparation
01/25/2011CA2436599C Oral pharmaceutical compositions comprising polyvinylpyrrolidone (pvp) and 5-cnac
01/25/2011CA2430857C Percutaneous absorption-type pharmaceutical preparation and process for producing the same
01/25/2011CA2426692C Block copolymers for multifunctional self-assembled systems
01/25/2011CA2425231C Patch and production method thereof
01/25/2011CA2410000C Compositions and methods comprising plasmid dna for wound healing and for repairing and regenerating tissue
01/25/2011CA2405030C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
01/25/2011CA2384425C Methods and compositions for delivery of pharmaceutical agents
01/25/2011CA2369175C Methods for stabilizing liquid nutritional products and products so stabilized
01/25/2011CA2363053C Clopidogrel bisulfate tablet formulation
01/25/2011CA2163278C Method for production of arachidonic acid
01/20/2011WO2011009039A2 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
01/20/2011WO2011008939A2 Porous-wall hollow glass microspheres as carriers for biomolecules
01/20/2011WO2011008923A2 Olopatadine nasal spray regimen for children
01/20/2011WO2011008770A2 Methods for inhibiting yellow color and peroxide formation in a composition
01/20/2011WO2011008674A1 Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
01/20/2011WO2011008298A2 Novel axomadol dosage forms
01/20/2011WO2011008193A1 Fusidic acid dosing regimens for treatment of bacterial infections
01/20/2011WO2011008183A1 Trimetazidine dihydrochloride-containing medication in the form of an extended-release matrix tablet (variants) and methods for preparing same (variants)
01/20/2011WO2011008001A2 Antihypertensive composition containing a ginsenoside-enriched fraction
01/20/2011WO2011007893A1 Eye drop with difluprednate for macular edema treatment
01/20/2011WO2011007838A1 Benzimidazole-based injection solution
01/20/2011WO2011007824A1 Antitumor composition and method for treating tumors
01/20/2011WO2011007795A1 Composition for inhibiting the expression of target gene
01/20/2011WO2011007792A1 Enzyme composition
01/20/2011WO2011007552A1 Bad breath-removing agent
01/20/2011WO2011007551A1 Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria
01/20/2011WO2011007353A1 Sustained-release drug carrier composition
01/20/2011WO2011007327A2 Suspension for therapeutic use and device for delivering said suspension
01/20/2011WO2011007153A1 Improvements in and relating to colon cleansing compositions
01/20/2011WO2011007082A1 Emulsion activatable by ultrasounds and method for producing same
01/20/2011WO2011007007A1 Orally administered bacteria as vehicles for systemic delivery of agents
01/20/2011WO2011006994A1 Hdl comprising a therapeutic agent and use in therapy
01/20/2011WO2011006670A1 Separating layers for pharmaceutical preparations to prevent interactions between medicinal drugs and pharmaceutical-technological adjuvants
01/20/2011WO2011006611A2 Pellets formulation
01/20/2011WO2011006596A2 Aqueous solution and gelatinized composition comprising a phosphodiesterase-5 inhibitor and corresponding methods and use
01/20/2011WO2011006510A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
01/20/2011WO2011006504A2 Treatment of hyperproliferative conditions
01/20/2011WO2011006453A1 Compound lipid based on pentaerythritol, intermediates, preparation method and use thereof
01/20/2011WO2010116385A3 Pharmaceutical compositions for alleviating unpleasant taste
01/20/2011WO2010111403A3 Probablistic pharmacokinetic and pharmacodynamic modeling
01/20/2011WO2010105995A3 Zoo-technical drug delivery device
01/20/2011WO2010104584A3 Articles and methods of treating vascular conditions
01/20/2011WO2010100506A3 Delivery system with scaffolds
01/20/2011WO2010099552A3 Devices, systems and methods for magnetic-assisted therapeutic agent delivery
01/20/2011WO2010095840A3 Donepezil resin complex
01/20/2011WO2010092088A3 Use of hydrophobin as a spreading agent
01/20/2011WO2010090502A3 External use composition containing cholecalciferol or its derivative for treating skin disorders
01/20/2011WO2010059534A3 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
01/20/2011WO2010035245A3 Extended release dosage form of ropinirole